Discover how the adoption of generative AI is driving productivity and reinvention for healthcare companies in Brazil.
Generative Artificial Intelligence (AI) is becoming a crucial tool for the healthcare sector in Brazil, bringing productivity and efficiency gains to companies. According to the 28th edition of the Global CEO Survey, 58% of healthcare CEOs in Brazil highlight the improvement in employee time management, exceeding the national average. QR Group, a specialist in healthcare product regulation, can be your partner to ensure that your company complies with new regulations while taking advantage of these technological innovations.
Impacts of AI on the Healthcare Sector
The most recent survey results reveal that 35% of healthcare CEOs in Brazil have noticed an increase in revenue thanks to the use of AI, surpassing the national average. Technology has also shown promise in increasing profitability, with 32% of leaders reporting financial gains. CEOs’ confidence in the use of AI in key processes is high, with 53% confident in the integration of this technology, a number higher than the national average of 51%.
This data underscores the importance of adopting generative AI, especially at a time of growing need for reinvention for healthcare companies. The survey points out that 47% of healthcare CEOs believe that their companies will not survive economically without this transformation.
How QR Group can help
QR Group understands the urgency of adapting to new technologies, such as generative AI, and how they impact the regulatory compliance of healthcare products. We offer specialized advice to ensure that technological innovations comply with ANVISA’s demanding regulations, facilitating the entry of new products into the Brazilian market.
QR Group is a leader in the regulation of health products in Brazil and is prepared to help companies ensure not only regulatory compliance, but also the maximization of the benefits of emerging technologies, such as AI.
With the increasing use of generative AI, healthcare companies can achieve significant gains in efficiency and profitability. Whether you’re a healthcare manufacturer or a healthcare professional, QR Group is the ideal partner to help your business navigate this challenging regulatory environment. Contact us and learn how we can help you on your innovation and compliance journey.
Contact QR Group today and find out how we can help your company ensure compliance with ANVISA regulations, while taking advantage of advances in generative AI.
Source: Pwc Brazil
